🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The death toll in #Lebanon is rising, and hospitals are overwhelmed with the influx of injured patients. The health system has been weakened by successive crises and is struggling to cope with the immense needs. I met with Arab League Ambassadors in Geneva to discuss the health

We are on the verge of an all-out war in Lebanon – with already devastating consequences. But there is still time to stop. The sovereignty and territorial integrity of all countries must be respected.

There are two million Lebanese Americans in the U.S. with relatives over there. They are in swing states like Michigan and Pennsylvania. If enough of them boycott the Lebanon-destroying Biden/Harris in November, the Democrats can pay dearly for their "iron bond" with the

🗞️ Microvascular Obstruction in cardiac #amyloidosis European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident bit.ly/4eSv92w

The toxic effect of light chain #amyloidosis. #AL . One of the cultural legacies of Prof Rapezzi 💡 🙏 Michele Emdin iacopo olivotto Giuseppe Limongelli CardioTomLuscher lupoten CardioInfo ANMCO SIC Società Italiana di Cardiologia

Ground breaking#EarlyTAVR trial Will change practice NNT=6!! Numerically less strokes, significantly less hospitalizations Philippe Genereux 👏👏👏

The #PowerofZero LGE by #WhyCMR? In a meta-analysis of 4,519 HCM pts w/ baseline CMR, LGE=0 was assoc w/ low annual risk for sudden death events & excellent long-term survival up to 10 yr follow-up. Zero LGE had strong NPV in 7-yr follow-up from baseline CMR

Colchicine in Acute Myocardial Infarction: NEJM 🥸 Here is the second CLEAR analysis - colchicine did not change outcomes post MI 😱 Good job AHA Science 👇👇👇

At #AHA24, Dr. Nanette Wenger reminds us we’re all ‘standing on the shoulders of giants’ in healthcare. As we celebrate 100 years of Scientific Sessions, we honor the pioneers who paved the way and look ahead to a new century of innovation.

AHA’24

Ramadan Kareem 🌙 As we embrace this blessed month of fasting, reflection, and prayer, let us remember those who are less fortunate. Ramadan is not only a time for spiritual growth but also for generosity and compassion. May we open our hearts and hands to those in need,

ACC 2025 LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters &research leaders for yet another fantastic year of innovation & research. 🫀❤️ 😊 #ACC2025 American College of Cardiology UW-Madison Division of Cardiovascular Medicine CardioNerds

ACC 2025

ACC 2025

ACC 2025

Excellent study in JACC Journals focusing on I-124 evuzamitide in patients with "early" transthyretin amyloidosis ( having negative or quivocal bone scintigraphy (PYP)). Excellent performance of evuzamitide in this cohort. jacc.org/doi/10.1016/j.… #CardioTwitter

we are closing after fantastic presentations from our faculties Drs Melissa Lyle , Christopher McLeod, David Wolinsky Dia Smiley David Snipelisky and very intersting quick cases. Thank you everyone who joined us at this ASNC Society webinar! #cvnuc #thinkamyloid #patientfirst

Is bone avid tracer cardiac scintigraphy always the preferred approach to screen at risk populations for TTR cardiac amyloidosis? Ahmad Masri Columbia Cardiology Fellows OHSU Knight Cardio #cvnuc Read both sides of the debate👇 bit.ly/4kCgv2f

We need better imaging to not only diagnose both TTR and AL Amyloidosis earlier, but also potentially track progression with treatments. I cannot thank mat maurer and Andrew Einstein SpencerDGuthrie and team enough for their guidance, patience and support. Thanks to Attralus

Thank you to David Wolinsky and Melissa Lyle for putting together such an amazing program over three parts. Tomorrow is the last part with exciting presentations!